This message was sent to ##Email##
|
|
|
|
|
| |
AST
The AST thanks the following organizations for their participation in the 2016 Corporate Affiliates Program:
- Alexion Pharmaceuticals
- Astellas Pharma US, Inc.
- Dompe
- Genentech, A Member of the Roche Group
- Gilead
- Merck
- Novartis Pharmaceuticals Corporation
- One Lambda, A Thermo Fischer Scientific Brand
- Sanofi
- Veloxis Pharmaceuticals
Become an AST Corporate Affiliate
The AST Corporate Affiliates Program provides an exciting opportunity for companies to support the work of the AST and receive tangible benefits throughout the year.
Benefits of participation include increased visibility, enhanced engagement opportunities, access to new marketing tools, and up-to- date communication about the latest research and advocacy efforts in the field of transplantation. For additional information, click here.
AST
The American Society of Transplantation and its Transplantation & Immunology Research Network are pleased to highlight new clinical trials in transplantation that are currently enrolling or will be in the near future. This service is a benefit of participation in AST’s Corporate Affiliates Program.
AST
The American Society of Transplantation (AST) is pleased to announce its call for nominations for 2017 Achievement Awards. Each year, the AST sponsors a variety of Achievement Awards in recognition of its members’ accomplishments and contributions to the field of transplantation. All nominations must be submitted by Friday, November 18, 2016. To view award categories and eligibility criteria, and to start your nomination, visit this link.
AST
The AST Transplantation and Immunology Research Network (TIRN) research grants program funds innovative research in basic, clinical, and translational science. A limited number of grants will be awarded for research projects beginning July 1, 2017. The request for proposals is open now at www.TIRN.org/funding.
ABIM
The ABIM has moved to standardize publication dates of these modules so that they are aligned with their fiscal year. Starting in 2017, the ABIM will synchronize the availability of all Annual Update modules to launch on July 1. Each new module will be named for the two calendar years it will span during its period of availability. Please review the letter when you have a moment to ensure your organization has the most up-to-date information about these modules. As you may know, there have been many changes at ABIM in the past year as they have begun an organization-wide effort to transform MOC in partnership with the internal medicine community. They note continued commitment to working with the societies to share advance notice of any additional changes to their products and programs with the AST in order to help ensure mutual awareness and collaboration. Please review a letter from ABIM’s Chief Medical Officer, Dr. Richard Battaglia, on these upcoming changes.
AST
Invite your colleagues to join AST now and receive the remainder of 2016 for FREE with a paid through date of 12/31/2017! All new members will be eligible to take advantage of AST member benefits, including discounted registration rates to ATC 2017.
For every new member successfully recruited, your name will be entered to win one of the following great prizes:
- Free membership for 2018
- $500 AST bucks
- $250 AST bucks
For more details, please visit the Pay it Forward page on the site.
READ MORE
AST
Check out AST's archived webinars and journal clubs, and watch educational content when it's convenient for you. AST also offers a variety of resources for different transplant specialties, all available on our easy-to-search website.
AST
Oct. 18, 2016 2 p.m. Online Activity
For more information: https://www.myast.org/education/webinars/t3
AST
Oct. 20, 2016 3:30 p.m. Online Activity
For more information: https://www.myast.org/education/astajt-journal-club/induction-immunosuppression-and-clinical-outcomes-hiv-infected-kidney
AST
Oct. 26, 2016 1 p.m. Online Activity
For more information: https://www.myast.org/education/webinars/optimizing-your-living-kidney-donor-program-1
Register today!
BeST16 Basic Science in Transplantation
The basic science community within our field is a tight-knit, dynamic group that benefits greatly from dedicated meeting opportunities to share knowledge and establish collaborations. As such, we hope you will join us at BeST16: Basic Science in Transplantation, a meeting jointly sponsored by the AST and ESOT.
HOUSING IS NOW OPEN
CEOT
The deadline to submit abstracts is Friday, November 18, 2016. To find out how to submit an abstract, please click here.
ATC
The American Transplant Congress is designed for physicians, surgeons, scientists, nurses, organ procurement personnel and pharmacists who are interested in the clinical and research aspects of solid organ and tissue transplantation. The meeting will provide the most current information in the field of transplant science. The deadline to submit abstracts is Friday, Dec. 2, 2016. For more information regarding abstract submission, please click here.
American Journal of Transplantation
High intrapatient variability (IPV) of tacrolimus concentrations is increasingly recognized as a predictor of poor outcome in solid organ recipients. How it relates to evolution of histology has not been explored. We analyzed tacrolimus IPV using the coefficient of variability (CV) from months 6–12 after transplantation in a cohort of 220 renal recipients for whom paired protocol biopsies at 3 mo and 2 years were available.
READ MORE
American Journal of Transplantation
U.S. transplant centers are required to report cancers in transplant recipients to the transplant network. The accuracy and completeness of these data, collected in the Scientific Registry of Transplant Recipients (SRTR), are unknown. We compared diagnoses in the SRTR and 15 linked cancer registries for colorectal, liver, lung, breast, prostate and kidney cancers; melanoma; and non-Hodgkin lymphoma (NHL).
READ MORE
American Journal of Transplantation
Ischemia-reperfusion injury–mediated primary graft dysfunction substantially hampers short- and long-term outcomes after lung transplantation. This condition continues to be diagnosed based on oxygen exchange parameters as well as radiological appearance, and therapeutic strategies are mostly supportive in nature. Identifying patients who may benefit from targeted therapy would therefore be highly desirable.
READ MORE
American Journal of Transplantation
Urinary messenger RNA (mRNA) quantification is a promising method for noninvasive diagnosis of renal allograft rejection (AR), but the quantification of mRNAs in urine remains challenging due to degradation. RNA normalization may be warranted to overcome these issues, but the strategies of gene normalization have been poorly evaluated.
READ MORE
Liver Transplantation
During gestation, the woman's body undergoes various changes, and the line between physiology and pathology is very thin even in healthy women. Today, many of the liver transplant recipients are young women, who at one point in their lives may consider the possibility of pregnancy. Clinicians have to counsel them about the time of conception, the risk of miscarriage, the deterioration of the mother's health status, and the risk of birth defects.
READ MORE
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
